COMMUNIQUÉS West-GlobeNewswire

Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C® to ACDF at Seven Years
01/12/2017
AUDUBON, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced the results of its seven-year clinical trial follow-up that demonstrate [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/12/2017
CAMBRIDGE, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors
30/11/2017
WARREN, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today announced the appointment of Ted Wang, Ph.D., Chief Investment Officer of [...]
Dawson James Securities Announces the Completion of Private Placement for Skyline Medical Inc. for Gross Proceeds of $1,300,000
30/11/2017
BOCA RATON, Fla., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. in conjunction with Skyline Medical Inc. closed a private placement of a newly created series of preferred stock designated as “Series C [...]
MPX Bioceutical Corporation Announces $25 Million Private Placement of Units
30/11/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) (the “Company” or “MPX”) announced today that it has entered into an agreement [...]
Retrophin to Present at the BMO 2017 Prescriptions for Success Healthcare Conference
30/11/2017
SAN DIEGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that Stephen Aselage, chief executive officer, will present at the BMO 2017 Prescriptions for Success Healthcare Conference in [...]
CAPS® to Showcase Its Quality Assurance Programs at ASHP
30/11/2017
IRVINE, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS) will showcase its 503B compounded drugs 100 percent release testing quality assurance program at this year’s American [...]
Vilacto Bio, Inc. Issues Statement About Promotional Activity Concerning Its Common Stock
30/11/2017
COPENHAGEN, Denmark, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Vilacto Bio, Inc. the “Company” (OTCQB:VIBI), today announced that it has been made aware of certain promotional activity concerning VIBI common stock. On November [...]
Global Blood Therapeutics Announces New Employment Inducement Grants
30/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that the compensation committee of the Company’s board of directors granted two new [...]
Assure Holdings Reports Strong Third Quarter 2017 Results
30/11/2017
PARKER, Colo., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, reported financial results for the third [...]
Transparency Information
30/11/2017
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (BELGIUM) - November 30, 2017, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 [...]
Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board
30/11/2017
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, today announced the addition [...]
Catalyst Pharmaceuticals, Inc. Announces Closing of Previously Announced Public Offering
30/11/2017
CORAL GABLES, Fla., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ) today reported that it has closed its previously announced public offering of shares of its common stock. The Company [...]
The Delta Companies Promotes DeLibra Wesley to Executive VP of Operations
30/11/2017
DALLAS, Nov. 30, 2017 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading staffing firm for healthcare professionals nationwide, announced that DeLibra Wesley has been promoted to Executive Vice President of [...]
Block Listing Update
30/11/2017
LONDON, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Title21 Health Solutions® to Showcase its BMT Software Solution 8.5 at the 2018 BMT Tandem Meeting
30/11/2017
PLEASANTON, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Title21 Health Solutions, “Title21”, an innovator of integrated enterprise software for blood and marrow transplant programs supporting high-quality and world-class [...]
VALNEVA Expands its Commercial Operations and Establishes US Infrastructure
30/11/2017
Valneva Expands its Commercial Operations and Establishes US Infrastructure Lyon (France), November 30, 2017 - Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving [...]
VALNEVA poursuit le développement de ses activités commerciales avec la mise en place d'une infrastructure aux Etats-Unis
30/11/2017
Valneva poursuit le développement de ses activités commerciales avec la mise en place d'une infrastructure aux Etats-Unis Lyon (France), 30 novembre 2017 - Valneva SE, ("Valneva" ou "le Groupe"), société de [...]
Hemostemix Drives Forward with Talented New Management into New Headquarters
30/11/2017
NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased [...]

Pages